Therapeutic efficacy of nanoparticles and routes of administration
D Chenthamara, S Subramaniam… - Biomaterials …, 2019 - spj.science.org
In modern-day medicine, nanotechnology and nanoparticles are some of the indispensable
tools in disease monitoring and therapy. The term “nanomaterials” describes materials with …
tools in disease monitoring and therapy. The term “nanomaterials” describes materials with …
Towards more accurate bioimaging of drug nanocarriers: turning aggregation-caused quenching into a useful tool
One of the current challenges in the monitoring of drug nanocarriers lies in the difficulties in
discriminating the carrier-bound signals from the bulk signals of probes. Environment …
discriminating the carrier-bound signals from the bulk signals of probes. Environment …
Relationship between particle size and lung retention time of intact solid lipid nanoparticle suspensions after pulmonary delivery
The relationship between the particle size and lung retention time of inhaled nanocarriers
was unclear, and this uncertainty hampered the design of nanocarriers for pulmonary …
was unclear, and this uncertainty hampered the design of nanocarriers for pulmonary …
Enhancing targeted cancer treatment by combining hyperthermia and radiotherapy using Mn–Zn ferrite magnetic nanoparticles
Y Wang, L Zou, Z Qiang, J Jiang, Z Zhu… - … Biomaterials Science & …, 2020 - ACS Publications
Radiotherapy (RT) is a major treatment method for non-small-cell lung cancer (NSCLC), and
development of new treatment modality is now critical to amplify the negative effects of RT …
development of new treatment modality is now critical to amplify the negative effects of RT …
Nanoparticle delivery platforms for RNAi therapeutics targeting COVID-19 disease in the respiratory tract
Since December 2019, a pandemic of COVID-19 disease, caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly spread across the globe. At …
respiratory syndrome coronavirus 2 (SARS-CoV-2), has rapidly spread across the globe. At …
Poly(lactide-co-glycolide) Nanoparticles Mediate Sustained Gene Silencing and Improved Biocompatibility of siRNA Delivery Systems in Mouse Lungs after …
L Wu, LP Wu, J Wu, J Sun, Z He… - … Applied Materials & …, 2021 - ACS Publications
Pulmonary delivery of small interfering RNA (siRNA)-based drugs is promising in treating
severe lung disorders characterized by the upregulated expression of disease-causing …
severe lung disorders characterized by the upregulated expression of disease-causing …
Major difference in particle size, minor difference in release profile: A case study of solid lipid nanoparticles
Solid lipid nanoparticles (SLN) have been widely used in a variety of drug delivery routes,
which have the outstanding advantage of controlled drug release. The release of SLN is …
which have the outstanding advantage of controlled drug release. The release of SLN is …
How can aggregation-caused quenching based bioimaging of drug nanocarriers be improved?
H Yuan, W Zhao, W Wu - Therapeutic Delivery, 2020 - Taylor & Francis
Drug-delivery systems (DDS) based on nanocarriers have been the focus of research for
more than 30 years, evidenced by the enormous input of investment and human resources …
more than 30 years, evidenced by the enormous input of investment and human resources …
[HTML][HTML] 纳米药物载体体内命运研究: 环境响应型荧光染料的应用
戚建平， 卢懿， 董肖椿， 赵伟利， 吴伟 - 药学学报, 2019 - html.rhhz.net
纳米制剂的体内命运研究关乎其临床转化的成败, 目前所面临的最大挑战之一是如何在体内实时
准确地监测纳米载体自身. 传统的放射或荧光探针从被标记母体粒子解离后, 依然发射信号 …
准确地监测纳米载体自身. 传统的放射或荧光探针从被标记母体粒子解离后, 依然发射信号 …